Obocell

Obocell is the brand name of a CNS stimulant and appetite suppressant (d-amphetamine phosphate) combined into one pill with a CNS depressant and first generation antihistamine (25mg methapyrilene). This combination formula was developed by Neisler Laboratories in 1951, approved for medical use in the United States by the U.S. Food and Drug Administration in 1953 to treat obesity. According to the National Institutes of Health, production or availability of Obocell was discontinued around 1967.
It was approved for medical use in the U.S. in 1953, and available for over the counter sales between 1953 and 1967, in the dosage form of a tablet, and indicated for treating obesity in patients by functioning as an appetite suppressant.
Wikipedia contributors, "Obocell", Wikipedia, revision 1366807968, retrieved 20 November 2026, source, CC BY-SA 4.0.